Jaguar Health (JAGX) Total Non-Current Liabilities (2014 - 2026)

Jaguar Health (JAGX) reported Total Non-Current Liabilities of $53.0 million for Q1 2026, up 375.84% year-over-year from $11.1 million in Q1 2025, and up 111.07% quarter-over-quarter from $25.1 million in Q4 2025.

Jaguar Health (JAGX) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 13 years of Total Non-Current Liabilities data on file, last reported at $53.0 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $53.0 million, up 375.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.0 million (up 375.84% YoY), and the FY2025 annual result was $25.1 million, up 176.24% from the prior year.
  • Total Non-Current Liabilities grew to $53.0 million in Q1 2026 per JAGX's latest filing, from $25.1 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $53.0 million in Q1 2026 and troughed at $9.1 million in Q4 2024.
  • A 5-year average of $22.3 million and a median of $14.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities tumbled 63.57% in 2023, then soared 375.84% in 2026.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $41.0 million in 2022, then plunged by 63.57% to $14.9 million in 2023, then sank by 39.09% to $9.1 million in 2024, then soared by 176.24% to $25.1 million in 2025, then surged by 111.07% to $53.0 million in 2026.
  • Business Quant data shows JAGX's Total Non-Current Liabilities at $53.0 million in Q1 2026, $25.1 million in Q4 2025, and $14.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 42,980.09
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 11.03 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.26 Bn 94.26 Bn - 64.76 Mn
10 Jaguar Health 1.44 Mn -10.19 Mn 19.11 Mn 53.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.00 Mn
Dec 31, 2025 25.11 Mn
Sep 30, 2025 14.69 Mn
Jun 30, 2025 12.58 Mn
Mar 31, 2025 11.14 Mn
Dec 31, 2024 9.09 Mn
Sep 30, 2024 10.09 Mn
Mar 31, 2024 9.13 Mn
Dec 31, 2023 14.92 Mn
Dec 31, 2022 40.97 Mn
Mar 31, 2022 44.80 Mn
Dec 31, 2021 41.41 Mn
Sep 30, 2021 37.70 Mn
Jun 30, 2021 37.75 Mn
Mar 31, 2021 36.81 Mn
Dec 31, 2020 25.64 Mn
Sep 30, 2020 28.30 Mn
Jun 30, 2020 21.07 Mn
Mar 31, 2020 15.42 Mn
Dec 31, 2019 14.34 Mn